Status:
COMPLETED
A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Despite recent advances in stent technology and clot reducing drug therapy, acute stent occlusion or thrombosis (ST), still occurs and can be life threatening. It has been shown that certain features ...
Eligibility Criteria
Inclusion
- Presence of a coronary artery stenosis undergoing percutaneous coronary intervention and stenting (PCI).
- Eligibility for drug eluting stent (DES) deployment.
- Stable or unstable coronary syndrome presentation, including ST elevation myocardial infarction (STEMI).
- Aged 18-90
Exclusion
- Contraindication to the use of a DES.
- Target lesion located within previous stent (in stent restenosis).
- Sustained haemodynamic instability following stent deployment (Systolic BP 90≤ mmHg or sustained ventricular arrhythmia).
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01201369
Start Date
September 1 2010
End Date
July 1 2011
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harefield Hospital
Harefield, Middlesex, United Kingdom, UB96JH